Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.

Source:http://linkedlifedata.com/resource/pubmed/id/19584825

Download in:

View as

General Info

PMID
19584825